ArticleScience translational medicine2025

The response to anti-PD-1 and anti-LAG-3 checkpoint blockade is associated with regulatory T cell reprogramming.

Annah S Rolig et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.